• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchTanvex Biopharma
    Picture of Tanvex Biopharma logo

    6541 — Tanvex Biopharma Share News

    TWD27.850.000.00%
    tw flag iconLast trade - 00:00
    HealthcareAdventurousSmall CapMomentum Trap
    • Market Cap
      TWD7.39bn
    • Enterprise Value
      TWD8.62bn
    • Revenue
      TWD400.97m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • 6541 Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    6541 Dividends
    • Brief: Tanvex Biopharma Announces Merger Plan With Unit Of Bora Pharmaceuticals

      27/08/2024 09:43
    • Brief: Tanvex Biopharma Says 2023 Net Loss At T$2.14 Bln

      14/03/2024 07:10
    • Brief: Tanvex Biopharma Says Board Approves Plan To Invest Up To $5 Mln In Taiwan Unit

      06/02/2024 07:03
    • Brief: Tanvex Biopharma Says 9-Month Net Loss At T$1.62 Bln

      13/11/2023 08:33
    • Brief: Tanvex Biopharma to issue 25 mln new shares for working capital supplement

      29/05/2018 10:21
    • Brief: Tanvex BioPharma says no dividend payment for 2017

      27/03/2018 07:49

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.